Abstract
The watch-and-wait-strategy (w/w) is already established in children with testicular tumours [1]. In young men this treatment approach is not a standard as insufficient compliance during follow-up increases the risk of late diagnosis of relapse [2]. To determine the value of w/w in non-testicular GCTs, we assessed the group of patients with malignant seminomatous and non-seminomatous GCTs treated in three consecutive German protocols.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Haas RJ, Schmidt P, Göbel U, Harms D. Treatment of malignant testicular tumors in childhood: results of the German National Study 1982–1992. Med Pediatr Oncol 1994;23:400–405
Foster RS, Nichols CR. Testicular cancer: what’s new in staging, prognosis and therapy. Oncology 1999; 13: 1689–1703
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag London Limited
About this paper
Cite this paper
Göbel, U., Calaminus, G., Engert, J., Harms, D., MAKEI Study Group. (2002). A Watch-and-Wait-Strategy Is a Safe Procedure in Children and Adolescents with Malignant Non-testicular Germ Cell Tumours (GCTs): Results of the German Consecutive MAKEI 83/86/89 and 96 Protocols. In: Harnden, P., Joffe, J.K., Jones, W.G. (eds) Germ Cell Tumours V. Springer, London. https://doi.org/10.1007/978-1-4471-3281-3_26
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3281-3_26
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3283-7
Online ISBN: 978-1-4471-3281-3
eBook Packages: Springer Book Archive